PhRMA Jumps Into Battle Over Mifepristone Regulation With Supreme Court Filing

 
• By Brenda Sandburg
Court Ruling
PhRMA expresses concern about an ‘unprecedented assault on FDA’s approval decisions.’ • Source: Alamy

More from US FDA

More from Agency Leadership